Funding opportunities

Below is a list of funding opportunities that may be of interest to the Ontario cancer research community.

If you wish to list a funding opportunity here, contact christopher.needles@oicr.on.ca.


Jump to: Cancer Therapeutics Innovation Pipeline | Health Services Research


Cancer Pathology Translational Research Grants

Ontario Molecular Pathology Research Network’s (OMPRN) vision is to create a province-wide network of pathologists collaborating to carry out high-quality cancer research with a clear potential for clinical utility. The OMPRN Steering Committee has developed objectives under the three broad themes of (i) Awareness & Outreach, (ii) Education, and (iii) Pathology-led Research. The Cancer Pathology Translational Research Grant (CPTRG) Streams address the latter objective by supporting projects in which the primary drivers are pathologists and the primary focus is on pathology cancer research.

Cancer Pathology Translational Research Grants will build the capacity of Ontario pathologists to undertake transdisciplinary research projects that advance the field of cancer diagnostic, prognostic or predictive testing and provide learning opportunities for pathology residents or early-career pathologists.

See more details


Cancer Therapeutics Innovation Pipeline – Call for Letters of Intent

Background

The Ontario Institute for Cancer Research (OICR) established the Cancer Therapeutics Innovation Pipeline (CTIP) strategic initiative to capitalize on Ontario’s expertise in cancer biology and drug discovery. CTIP aims to support the translation of Ontario discoveries into therapeutic assets with the potential for improving the lives of cancer patients.

To stimulate collaborative research with the Ontario cancer research community in the area of cancer therapeutics discovery, OICR invites applications for early stage drug discovery. This call for letters of intent (LOI) is for Early Accelerator projects.

Early Accelerator Projects

Focus on target identification/validation experiments and the generation of a validated primary assay to enable initial screening against a defined target.

Funding

Up to $100,000 per year for a maximum of one year.

Eligibility

  • Investigators at Ontario academic institutions, small biotechs or start-up companies seeking support for early stage drug discovery are eligible to apply;
  • LOIs that do not align with the aims of an Early Accelerator project as described above are ineligible.

Timeline

Activity Date
LOI deadline August 13, 2018 by 5 p.m. EDT
Response to LOI applicants August 22, 2018
Full application deadline September 21, 2018 by 5 p.m. EDT
Notification of results November/December 2018
Funding to begin April 1, 2019

Forms

Download the Request for Applications [PDF]

 

Questions

Contact OICR’s Scientific Secretariat department: scientificsecretariat@oicr.on.ca


New Funding Opportunity – Health Services Research

Background

In collaboration with Cancer Care Ontario, the Ontario Institute for Cancer Research (OICR) is excited to announce a new funding opportunity to support health services research projects that will provide the knowledge needed to optimize the delivery of cancer services today and to ensure appropriate dissemination of health service innovations and well-evaluated technologies.

Available funding

Up to $150,000 per year for a maximum of two years for projects related to one of the following priority areas. Projects that address hard-to-treat cancers and/or have a clear trajectory to intervention studies are preferred.

  1. Data infrastructure, integration and mobilization studies (e.g., data linkage, quality, access, governance, and policy, including privacy and ethics considerations);
  2. Use of Real-World Evidence to advance innovations in health care and health technology assessments;
  3. Research addressing health care system adoption of accepted best practices related to precision medicine;
  4. Use of artificial intelligence and digital health tools by health care systems and their impact on access to care, models of care, quality and cost of care, and patient outcomes;
  5. Knowledge translation and dissemination projects; and
  6. Population health studies (e.g., prevention and screening).

Eligibility

Individuals based in, or formally affiliated with, an Ontario Host Institution, such as a university, research institute, research hospital, or not-for-profit organization with an explicit research mandate.

Timeline

Activity Date
Registration deadline August 17, 2018 by 5:00 p.m. EDT
Response to registrants August 24, 2018
Letter of Intent (LOI) deadline September 14, 2018 by 5 p.m. EDT
Response to LOI applicants End of October 2018
Full application deadline November 26, 2018 by 5 p.m. EST
Funding to begin April 1, 2019
Funding term end date (maximum) March 31, 2021

Questions

Contact OICR’s Scientific Secretariat department: scientificsecretariat@oicr.on.ca

This opportunity is funded in collaboration with Cancer Care Ontario.